FSD Pharma Inc. (NASDAQ: HUGE) has renewed a service agreement with shareholder intelligence services provider ShareIntel LLC to assist in ongoing investigations related to suspected naked short selling of the company’s common stock.

Over recent years, FSD Pharma’s management received several shareholder requests on the discrepancy between buying and selling data of HUGE stock by different banks and broker-dealers. 

After a year-long daily basis analysis of data and obtaining no reply from broker-dealers in view of the evident imbalance in trade activity, FSD has decided to pursue additional avenues in order to provide clarity to shareholders. 

This could include retaining …

Full story available on Benzinga.com